293 Development of a MUC16-specific CAR-T cell exhibiting potent antitumor activity for the treatment of patients with recurrent ovarian cancer

• Prashant R Nambiar,
• Nicole A Protheroe,
• Kelly DellaGrotte,
• Harini Kantamneni,
• Sumati Sundaram,
• Scott F Heller,
• Christina Ferren,
• Collin Walter,
• Corinne Decker,
• Alison Crawford,
• Tina Chang Albershardt

Affiliations

Prashant R Nambiar

bluebird bio Inc, Cambridge, Massachusetts, USA

Nicole A Protheroe

12seventy bio, Cambridge, MA, USA

Kelly DellaGrotte

12seventy bio, Cambridge, MA, USA

Harini Kantamneni

12seventy bio, Cambridge, MA, USA

Sumati Sundaram

12seventy bio, Cambridge, MA, USA

Scott F Heller

12seventy bio, Cambridge, MA, USA

Christina Ferren

12seventy bio, Cambridge, MA, USA

Collin Walter

12seventy bio, Cambridge, MA, USA

Corinne Decker

2Regeneron Pharmaceuticals, Tarrytown, NY, USA

Alison Crawford

2Regeneron Pharmaceuticals, Tarrytown, NY, USA

Tina Chang Albershardt

12seventy bio, Cambridge, MA, USA